TelyRx Holdings Inc.

C$2.29As of Sun 8 Nov 2026, 12:00 UTC
TSX:TELYHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (802.88%)
Pharmaceutical Retailers
Beta (5Y) —
PE TTM —
TSR TTM (23.67%)
Mkt cap C$111.9M
ROIC (63.99%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.55
11.40%
(73.25%)
Hold 10|7|4|0|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
32.89%
18.00%
13.87%
8.60%
Revenue$M
11.45
11.88
12.48
12.35
11.30%
14.10%
20.14%
13.28%
Peers (US$79.18M)
Cap (US$)
PE
235.3M
—
55.07M
—
41.19M
37.78x
Capital
TTM
5Y
10Y
Leveragex
0.976
(1.362)
(1.113)
EBIT/Intx
19.07
0.133
0.172
Own earn%
122.25
(33.45)
(46.98)
Sh yield%
32.55
21.60
24.47
Owners
Insiders/Inst%
3.53
82.20
Short interest%
4.40
SBC / revenue%
0.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
3–8
$1 testx
—
Incr. ROIC%
7